Table 3

A list of statements

StatementsLevel of evidenceLevel of recommendation% of agreement
1.1Risk stratification with regard to upper gastrointestinal (UGI) cancers should be performed before diagnostic oesophagogastroduodenoscopy (OGD)IIIB100%
1.2Presence of endoscopic high-risk findings for UGI cancers should raise the index of suspicion of the endoscopistsIIIB100%
2Presence or absence of premalignant mucosal changes during OGD should be documentedIIIC100%
3.1Use of sedation is recommended to enhance the detection rate of superficial neoplasm of the oesophagus and stomachIIIC80%
3.2Use of an antispasmodic agent is recommended to enhance the detection rate of OGD and image enhanced endoscopy (IEE)IIIC80%
3.3Use of mucolytic and/or defoaming agents is recommended for the improvement of visual clarity of OGD and IEEIA100%
4Systematic endoscopic mapping of the entire oesophagus and stomach may improve the detection rate of UGI superficial neoplasmIIIC100%
5Sufficient examination time is recommended to increase the detection rate of UGI superficial neoplasiaIIB89%
6Structured training improves the detection rate of UGI superficial neoplasiaII-3C97%
7.1IEE in addition to white light endoscopy (WLI) improves the detection rate of oesophageal superficial neoplasiaIA100%
7.2IEE in addition to WLI improves the detection rate of gastric premalignant mucosal changes such as gastric intestinal metaplasia and atrophyIA93%
8IEE in addition to WLI is useful for the delineation of UGI superficial neoplasiaII-2B97%
9Magnifying endoscopy with narrow band imaging (NBI) is recommended for better characterisation of UGI superficial neoplasiaIA100%
10Endoscopic characterisation with IEE avoids unnecessary biopsies for UGI superficial lesionsIB97%